Christopher Bush

2.7k total citations
24 papers, 1.0k citations indexed

About

Christopher Bush is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Christopher Bush has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 7 papers in Epidemiology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Christopher Bush's work include Opioid Use Disorder Treatment (7 papers), Hormonal Regulation and Hypertension (6 papers) and Substance Abuse Treatment and Outcomes (5 papers). Christopher Bush is often cited by papers focused on Opioid Use Disorder Treatment (7 papers), Hormonal Regulation and Hypertension (6 papers) and Substance Abuse Treatment and Outcomes (5 papers). Christopher Bush collaborates with scholars based in United States, Switzerland and Germany. Christopher Bush's co-authors include Deborah Keefe, Amy S. B. Bohnert, Pooja Lagisetty, Michele Heisler, Katarzyna Klasa, Vineet Chopra, Robert Cherill, Sudha R. Raman, Andrew W. Roberts and Asheley Cockrell Skinner and has published in prestigious journals such as Circulation, PLoS ONE and Biometrika.

In The Last Decade

Christopher Bush

23 papers receiving 968 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Bush United States 14 284 212 207 206 195 24 1.0k
Jonathan H. Watanabe United States 16 72 0.3× 13 0.1× 176 0.9× 32 0.2× 25 0.1× 63 973
G Lagier France 12 43 0.2× 12 0.1× 100 0.5× 72 0.3× 18 0.1× 57 1.0k
A Wisniewski United Kingdom 17 32 0.1× 14 0.1× 103 0.5× 18 0.1× 51 0.3× 25 1.4k
Kenneth Lai United States 17 36 0.1× 161 0.8× 49 0.2× 43 0.2× 6 0.0× 27 762
Demissie Alemayehu United States 15 122 0.4× 14 0.1× 48 0.2× 20 0.1× 65 0.3× 51 595
C. Kreft-Jaïs France 14 104 0.4× 6 0.0× 44 0.2× 41 0.2× 40 0.2× 38 774
Rupa Makadia United States 7 81 0.3× 123 0.6× 69 0.3× 9 0.0× 31 0.2× 12 598
Alan Ebbutt United Kingdom 10 172 0.6× 9 0.0× 91 0.4× 4 0.0× 283 1.5× 17 1.2k
Joseph M. Plasek United States 13 15 0.1× 127 0.6× 55 0.3× 19 0.1× 14 0.1× 42 544
Riaz Qureshı United States 16 12 0.0× 46 0.2× 255 1.2× 46 0.2× 9 0.0× 61 777

Countries citing papers authored by Christopher Bush

Since Specialization
Citations

This map shows the geographic impact of Christopher Bush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Bush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Bush more than expected).

Fields of papers citing papers by Christopher Bush

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Bush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Bush. The network helps show where Christopher Bush may publish in the future.

Co-authorship network of co-authors of Christopher Bush

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Bush. A scholar is included among the top collaborators of Christopher Bush based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Bush. Christopher Bush is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bush, Christopher, Katherine E. Mues, Ekkehard Beck, et al.. (2024). Real-world comparative effectiveness of a third dose of mRNA-1273 versus BNT162b2 among adults aged ≥ 65 years in the United States. Vaccine. 42(25). 126113–126113. 4 indexed citations
2.
3.
Li, Zhen, et al.. (2022). Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study. Addiction Science & Clinical Practice. 17(1). 60–60. 4 indexed citations
4.
Hung, Anna, Christopher Bush, Melissa A. Greiner, et al.. (2020). Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population. Journal of Managed Care & Specialty Pharmacy. 26(2). 169–175. 8 indexed citations
5.
Foraker, Randi E., Christopher Bush, Melissa A. Greiner, et al.. (2019). Distribution of Cardiovascular Health by Individual- and Neighborhood-Level Socioeconomic Status: Findings From the Jackson Heart Study. Global Heart. 14(3). 241–241. 33 indexed citations
6.
Raman, Sudha R., et al.. (2019). Characteristics of New Opioid Use Among Medicare Beneficiaries: Identifying High-Risk Patterns. Journal of Managed Care & Specialty Pharmacy. 25(9). 966–972. 14 indexed citations
7.
Bush, Christopher, et al.. (2019). Long‐term opioid therapy definitions and predictors: A systematic review. Pharmacoepidemiology and Drug Safety. 29(3). 252–269. 70 indexed citations
8.
Fernandez, Anne C., Christopher Bush, Erin E. Bonar, et al.. (2018). Alcohol and Drug Overdose and the Influence of Pain Conditions in an Addiction Treatment Sample. Journal of Addiction Medicine. 13(1). 61–68. 18 indexed citations
9.
Lagisetty, Pooja, Katarzyna Klasa, Christopher Bush, et al.. (2017). Primary care models for treating opioid use disorders: What actually works? A systematic review. PLoS ONE. 12(10). e0186315–e0186315. 105 indexed citations
10.
Shaddy, Robert E., Charles E. Canter, Nancy Halnon, et al.. (2017). Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study). American Heart Journal. 193. 23–34. 59 indexed citations
11.
Gradman, Alan H., et al.. (2010). Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies. Journal of Human Hypertension. 24(11). 721–729. 26 indexed citations
12.
Jarugula, Venkateswar, Ching‐Ming Yeh, Dan Howard, et al.. (2010). Influence of Body Weight and Gender on the Pharmacokinetics, Pharmacodynamics, and Antihypertensive Efficacy of Aliskiren. The Journal of Clinical Pharmacology. 50(12). 1358–1366. 14 indexed citations
13.
Palatini, Paolo, Won‐Sang Jung, Е. V. Shlyakhto, et al.. (2009). Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study. Journal of Human Hypertension. 24(2). 93–103. 56 indexed citations
14.
15.
Bush, Christopher, et al.. (2008). A Wellness Intervention Program for Patients With Mental Illness. The Primary Care Companion to The Journal of Clinical Psychiatry. 10(4). 329–331. 7 indexed citations
16.
Bush, Christopher, et al.. (2007). Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysis. Journal of the American Society of Hypertension. 1(4). 264–277. 78 indexed citations
17.
Ho, Vincent, Aditya K. Gupta, Roland Kaufmann, et al.. (2003). Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants. The Journal of Pediatrics. 142(2). 155–162. 151 indexed citations
18.
Bush, Christopher, et al.. (2001). SDZ ASM 981 cream 1% is effective and safe in children and adolescents with atopic dermatitis. Clinical and Experimental Dermatology. 26(2). 214–215. 4 indexed citations
19.
Bush, Christopher. (1996). A semiparametric Bayesian model for randomised block designs. Biometrika. 83(2). 275–285. 233 indexed citations
20.
Bush, Christopher. (1994). Semi-parametric Bayesian linear models /. OhioLink ETD Center (Ohio Library and Information Network). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan H. Watanabe Breakdown of academic impact, for papers by G Lagier Breakdown of academic impact, for papers by A Wisniewski Breakdown of academic impact, for papers by Kenneth Lai Breakdown of academic impact, for papers by Demissie Alemayehu Breakdown of academic impact, for papers by C. Kreft-Jaïs Breakdown of academic impact, for papers by Rupa Makadia Breakdown of academic impact, for papers by Alan Ebbutt Breakdown of academic impact, for papers by Joseph M. Plasek Breakdown of academic impact, for papers by Riaz Qureshı
Rankless by CCL
2026